SOLVONIS THERAPEUTICS PLC

Active London

Other professional, scientific and technical activities n.e.c.

3 employees website.com
Other professional, scientific and technical activities n.e.c.
S

SOLVONIS THERAPEUTICS PLC

Other professional, scientific and technical activities n.e.c.

Founded 18 May 2017 Active London, United Kingdom 3 employees website.com
Other professional, scientific and technical activities n.e.c.

Previous Company Names

GRAFT POLYMER (UK) PLC 1 Jul 2021 — 10 Jan 2025
GRAFT POLYMER (UK) LIMITED 18 May 2017 — 1 Jul 2021
Accounts Submitted 7 May 2025 Next due 30 Jun 2026 2 months remaining
Confirmation Submitted 27 May 2025 Next due 31 May 2026 1 month remaining
Net assets £3M £1M 2024 year on year
Total assets £3M £769K 2024 year on year
Total Liabilities £119K £289K 2024 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Eccleston Yards 25 Eccleston Place London SW1W 9NF United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for SOLVONIS THERAPEUTICS PLC (10776788), an active company based in London, United Kingdom. Incorporated 18 May 2017. Other professional, scientific and technical activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type Total Exemption Full
Next accounts 31 December 2025
Due by 30 September 2026 9 months

Net Assets, Total Assets & Total Liabilities (2018–2024)

Cash in Bank

£757.00k

Increased by £602.00k (+388%)

Net Assets

£3.08M

Increased by £1.06M (+52%)

Total Liabilities

£119.00k

Decreased by £289.00k (-71%)

Turnover

N/A

Decreased by £587.00k (-100%)

Employees

3

Debt Ratio

4%

Decreased by 13 (-76%)

Financial History

Revenue, profit, EBITDA and key financial figures

2024
Dec Year End
2023
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Share Capital

Share Capital

Share allotments and capital structure

11 Allotments 6,765,806,194 Shares £3908100009.44m Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
3 Sept 202523,636,362£78k£0.003
3 Sept 202581,732,308£106k£0.001
3 Sept 202560,142,923£180k£0.003
3 Sept 2025378,787,876£1.25m£0.003
24 Jul 202520,000,000£20k£0.001

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (20)

William Potts
23.2%
Alba Capital Pty Ltd
11.2%

Persons with Significant Control

Persons with Significant Control (0)

0 Active 3 Ceased

Chitta Lu Limited

Ceased 6 Sept 2017

Ceased

Victor Bolduev

Ceased 4 Jan 2024

Ceased

Robert Neville Chisholm Eastman & Elizabeth Anne Eastman A/t Neville Eastman Family Trust

Ceased 6 Sept 2017

Ceased

Group Structure

Group Structure

SOLVONIS THERAPEUTICS PLC Current Company
GRAFTBIO LIMITED united kingdom

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
5 Jan 2026OfficersAppointment of Paul Rutherford Carter as director on 2025-10-27
20 Nov 2025CapitalAllotment of shares (GBP 6,806,403.493) on 2025-11-07
15 Oct 2025AuditorsAuditors Resignation Company
29 Jul 2025CapitalAllotment of shares (GBP 6,262,104.024) on 2025-07-24
17 Jul 2025CapitalAllotment of shares (GBP 6,242,104.02) on 2025-07-10
5 Jan 2026 Officers

Appointment of Paul Rutherford Carter as director on 2025-10-27

20 Nov 2025 Capital

Allotment of shares (GBP 6,806,403.493) on 2025-11-07

15 Oct 2025 Auditors

Auditors Resignation Company

29 Jul 2025 Capital

Allotment of shares (GBP 6,262,104.024) on 2025-07-24

17 Jul 2025 Capital

Allotment of shares (GBP 6,242,104.02) on 2025-07-10

Recent Activity

Latest Activity

Appointment of Paul Rutherford Carter as director on 2025-10-27

3 months ago on 5 Jan 2026

Allotment of shares (GBP 6,806,403.493) on 2025-11-07

4 months ago on 20 Nov 2025

Auditors Resignation Company

6 months ago on 15 Oct 2025

Allotment of shares (GBP 6,262,104.024) on 2025-07-24

8 months ago on 29 Jul 2025

Allotment of shares (GBP 6,242,104.02) on 2025-07-10

9 months ago on 17 Jul 2025